Neisseria meningitidis antigens and compositions

Details for Australian Patent Application No. 2006202355 (hide)

Owner The Institute for Genomic Research Novartis Vaccines and Diagnostics, Inc.

Inventors Galeotti, Cesira; Scalato, Enzo; Mora, Mariarosa; Scarselli, Maria; Masignani, Vega; Fraser, Claire; Tettelin, Herve; Hickey, Erin; Venter, J Craig; Pizza, Mariagrazia; Grandi, Guido; Rappuoli, Rino; Ratti, Giulio; Petersen, Jeremy

Agent FB Rice

Pub. Number AU-B-2006202355

Parent 2003235364

Filing date 2 June 2006

Wipo publication date 22 June 2006

Acceptance publication date 20 August 2009

International Classifications

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

A61K 39/095 (2006.01) Medicinal preparations containing antigens or antibodies - Neisseria

C07K 14/22 (2006.01) Peptides having more than 20 amino acids

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

22 June 2006 Application Open to Public Inspection

  Published as AU-B-2006202355

22 June 2006 Complete Application Filed

24 April 2008 Assignment before Grant

  Institute for Genomic Research; Chiron Corporation The application has been assigned to The Institute for Genomic Research; Novartis Vaccines and Diagnostics, Inc.

20 August 2009 Application Accepted

  Published as AU-B-2006202355

5 November 2009 Alteration of Name

  The name of the applicant has been altered to The Institute for Genomic Research; Novartis Vaccines and Diagnostics, Inc.

17 December 2009 Standard Patent Sealed

18 February 2010 Assignment Registered

  Novartis Vaccines and Diagnostics, Inc.; The Institute for Genomic Research The patent has been assigned to Novartis Vaccines and Diagnostics, Inc.; J. Craig Venter Institute ,Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006202356-Implantable medical device with cover and method

2006202354-Improved Agricultural Implement